Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Ascending Dose Study of M529101 in Healthy Male Subjects
jRCT2031210455Phase 1Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Dec 2021
- Countries
- 1
01
Overview
Phase 1 trial in stomatitis and mucositis (2 arms), sponsored by Maruho Co., Ltd. Primary endpoints: Safety and tolerability of single ascending doses of 2% M529101 and Pharmacokinetics of M529101. Started Dec 2021; status: completed.
02
Conditions
stomatitismucositis
Beyond the preview
Go deeper on jRCT2031210455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210455.